Remote Weight-Loss Intervention Improves Quality of Life for Breast Cancer Survivors

A new, remote weight-loss intervention has demonstrated significant improvements in physical function and quality of life for women living with breast cancer and obesity. Findings from the Breast Cancer Weight Loss (BWEL) trial, presented at the American Society of Clinical Oncology (ASCO) Annual Meeting, suggest that structured, telephone-based lifestyle support can provide lasting benefits for cancer survivors.

Key Takeaways

• The remote intervention significantly improved physical function, mental health, and social functioning in participants.
• Benefits of the program were observed as early as 6 months and persisted for up to 2 years.
• The study highlights the potential for integrating lifestyle interventions into standard survivorship care plans.

The BWEL Trial: A Remote Approach

The phase 3 BWEL study enrolled 3,180 women diagnosed with stage 2 or 3 HER2-negative breast cancer who also had a body mass index (BMI) of 27 kg/m² or higher. Researchers aimed to evaluate the impact of a 2-year, remote weight-loss program compared to standard health education alone.

Participants in the intervention arm worked individually with coaches via a call center. The program focused on reducing caloric intake and increasing physical activity. While participants were provided with activity monitors and meal replacement options, their use was not mandatory, emphasizing the program’s flexibility. The study was notably far-reaching, with patients enrolled from 637 oncology centers across the United States and Canada.

Long-Term Quality of Life Benefits

This analysis, which focused on the first 542 participants, measured changes in physical function as the primary endpoint. Secondary endpoints included global mental and physical health, as well as fatigue and social engagement.

The results showed that women in the intervention group experienced superior physical function at both 6 and 24 months compared to the control group. Participants reported significant improvements in global physical and mental health, as well as social roles and activities. While improvements in fatigue were noted early on, the difference between the intervention and control groups in this specific metric diminished over time.

Jennifer A. Ligibel, MD, of the Dana-Farber Cancer Institute, noted that while quality of life metrics improved in both groups over the course of the study, the weight-loss intervention group saw more significant and rapid gains. These findings reinforce the value of providing structured support to survivors who are navigating the physical and emotional challenges of cancer recovery.

Integrating Lifestyle Support into Survivorship Care

The medical community is increasingly viewing lifestyle interventions as a crucial component of comprehensive cancer care. Julie R. Gralow, MD, FACP, FASCO, chief medical officer of ASCO, emphasized that the benefits observed in the BWEL study suggest a need to move beyond viewing lifestyle support as an optional add-on. Instead, there is a growing consensus that such programs should be integrated into standard survivorship care plans.

As the BWEL trial continues, researchers are looking to evaluate further endpoints, including how weight loss and improved physical function correlate with a survivor’s ability to participate in the workforce and the potential impact on cardiovascular health. The ultimate goal for investigators is to establish these programs as a standard, insurance-covered component of breast cancer treatment.

Source: Ligibel JA, et al. Abstract 12010. Presented at: ASCO Annual Meeting; May 29-June 2, 2026; Chicago.